Latest Regulatory News

Peppermint Innovation Ltd has raised A$500,000 to accelerate the rollout of its bizmoto digital wallet platform across the Philippine cooperative sector, targeting millions of members and aiming to boost transaction frequency and recurring revenue.

Investor Kjerulf Ainsworth has initiated an unconditional off-market proportional takeover bid for 2.9% of Ainsworth Game Technology shares at $1.30 each, offering shareholders a significant premium and liquidity option.

Nova Minerals has priced a US$20 million NASDAQ offering to fund exploration and development at its Estelle Gold and Critical Minerals Project in Alaska, signaling a key step forward for the company’s growth ambitions.

Burgundy Diamond Mines' subsidiary Arctic Canadian Diamond Company has secured a C$115 million senior secured loan from Canada's LETL facility to support operations amid US tariffs impacting diamond markets. The funding enables continued development and operational restructuring at the Ekati mine.

Imricor Medical Systems has secured Charité University Hospital in Berlin as the second global site for its VISABL-VT clinical trial, marking a significant milestone in real-time MRI-guided cardiac ablation technology.

Bass Oil reported a 2% rise in November oil production alongside a new gas sales agreement with Origin Energy, setting the stage for first gas sales in 2026. Indonesian operations also advanced with production enhancements and upcoming drilling plans.

HyTerra Limited has unveiled a comprehensive Strategic Plan targeting commercialisation of its Kansas hydrogen project and ambitious expansion across the US and globally. The plan leverages proprietary technology and recent drilling successes to position the company at the forefront of the emerging geologic hydrogen sector.

Sarytogan Graphite Limited updates investors on its $5 million capital raising, highlighting regulatory approval delays but confirming near-term funding to advance its key graphite project.

ASX has suspended Terra Critical Minerals Limited’s T92OA securities from quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Star Minerals Limited has requested an extension to its voluntary suspension on the ASX as it awaits a Supreme Court ruling on the appointment of its auditor, with a market update expected soon.

PYC Therapeutics reports positive safety outcomes from the initial phase of its clinical trial for PYC-003, a promising treatment for Polycystic Kidney Disease. The drug was well tolerated in healthy volunteers, paving the way for patient dosing and further trials.

The ACCC’s final report slashes regulated voice interconnection rates, prompting Aussie Broadband to forecast a multi-million dollar EBITDA impact from FY27 and plan mitigation strategies.